Indies Pharma Jamaica Limited reported earnings results for the fourth quarter ended October 31, 2021. For the fourth quarter, the company reported sales was JMD 213.54 million compared to JMD 200.11 million a year ago. Net income was JMD 54.03 million compared to JMD 48.07 million a year ago. Basic earnings per share from continuing operations was JMD 0.04 compared to JMD 0.04 a year ago.